Nanaz Mohtashami's most recent trade in Hologic, Inc. was a trade of 3,190 Common Stock done . Disclosure was reported to the exchange on Feb. 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Hologic | Nanaz Mohtashami | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 3,190 | 7,371 (0%) | 0% | - | Common Stock | |
| Hologic | Nanaz Mohtashami | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 5,535 | 5,535 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Nanaz Mohtashami | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2025 | 1,864 | 4,181 (0%) | 0% | - | Common Stock | |
| Hologic | Nanaz Mohtashami | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 4,536 | 4,536 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Hologic | Nanaz Mohtashami | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 1,572 | 2,317 (0%) | 0% | - | Common Stock |